Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
control group :western medicine symptomatic treatment
Sponsors
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria forconfirmed cases in the Diagnosis and Treatment of Pneumonia of New Coronavirus Pneumonia (Trial Version 5); 2. The acute stage is complicated by sepsis, respiratory failure, ARDS and so on. The patients are with multiple organ damage when improved and tended to recover after organ support and other treatments; 3. Meet the TCM diagnostic criteria for the recovery period; 4. Aged 18-75 years-old men or women; 5. Patients who volunteer to participate in this study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with respiratory failure, acute necrotizing encephalopathy, septic shock, multiple organ dysfunction, and other serious clinical conditions requiring monitoring and treatment when enrolled; 2. Pregnant, preparing or lactating women; 3. Patients with severe heart, cerebrovascular and liver, kidney, hematopoietic system diseases and mental illness; 4. Patients with tuberculosis, measles, AIDS and other infectious diseases; 5. Patients with known allergies to western medicine or traditional Chinese medicine ingredients used in this research; 6. Patients with gastrointestinal bleeding who cannot take Chinese medicine; 7. Patients who use oral Chinese medicine within 4 weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lung function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total duration of disease;Time needed for healing;Incidence of adverse events;Number of sequelae;SF-36;Mental health scale; | — |
Countries
China
Contacts
Public ContactLU Zhenhui
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed